Aug 26, 2022
RhoVac AB ("RhoVac") announces today, August 26th 2022, that the board has decided to appoint board member Lars Hedbys as acting CEO of RhoVac, starting from September 1, 2022. As previously announced, Anders Månsson submitted his resignation on 15 July and will take up his new position on 1 September.
Gunnar Gårdemyr, chairman of the board: "As Lars has worked on the board of RhoVac since 2015 and has experience from similar assignments, he is well suited to take over the role of acting CEO at Rhovac during the period until RhoVac's future is decided."
This disclosure contains information that RhoVac is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 26-08-2022 08:36 CET.